## Abstract Immunotherapeutic approaches designed to induce a humoral immune response have recently been developed for possible vaccination to the treatment of Alzheimer's disease (AD). Based on the identification of Aβ(4–10) (FRHDSGY) as the predominant B‐cell epitope recognized by therapeutically
Alzheimer’s disease: amyloidβ-peptide antibody vaccine as plaque remover
✍ Scribed by Arun Kumar
- Book ID
- 110637889
- Publisher
- Indian Academy of Sciences
- Year
- 2000
- Tongue
- English
- Weight
- 24 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0250-5991
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Amyloid formation plays a central role in the cause and progression of Alzheimer's disease. The major component of this amyloid is the amyloid‐β (Aβ) peptide, which is currently the subject of intense study. This review discusses some recent studies in the area of Aβ synthesis, purifica
A new series of diphenylpropynone (DPP) derivatives for use in vivo to image β-amyloid (Aβ) plaques in the brain of patients with Alzheimer's disease (AD) were synthesized and characterized. Binding experiments in vitro revealed high affinity for Aβ (1-42) aggregates at a K(i) value ranging from 6 t